# To Verify the Efficacy of Z-338 in Subjects With Functional Dyspepsia

> **NCT00761358** · PHASE3 · COMPLETED · sponsor: **Zeria Pharmaceutical** · enrollment: 820 (estimated)

## Conditions studied

- Functional Dyspepsia

## Interventions

- **DRUG:** Z-338
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00761358
- **Lead sponsor:** Zeria Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2010-06
- **Final completion:** 2010-08
- **Target enrollment:** 820 (ESTIMATED)
- **Last updated:** 2010-11-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00761358

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00761358, "To Verify the Efficacy of Z-338 in Subjects With Functional Dyspepsia". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00761358. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*